• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form DEFA14A filed by Accendra Health Inc.

    4/2/26 6:30:09 AM ET
    $ACH
    Medical Specialities
    Health Care
    Get the next $ACH alert in real time by email
    DEFA14A 1 ach-20260401xdefa14a.htm DEFA14A

    ​

    ​

    UNITED STATES

    SECURITIES AND EXCHANGE COMMISSION

    Washington, D.C. 20549


    SCHEDULE 14A

    (Rule 14a-101)

    INFORMATION REQUIRED IN PROXY STATEMENT

    SCHEDULE 14A INFORMATION

    Proxy Statement Pursuant to Section 14(a) of the

    Securities Exchange Act of 1934


    Filed by the Registrant  ☒

        

    Filed by a party other than the Registrant  ☐

    ​

    Check the appropriate box:

    ☐

    Preliminary Proxy Statement

    ☐

    Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))

    ☐

    Definitive Proxy Statement

    ☒

    Definitive Additional Materials

    ☐

    Soliciting Material Pursuant to §240.14a-12

    Accendra Health, Inc.

    (Name of Registrant as Specified in its Charter)

    Not applicable.

    (Name of Person(s) Filing Proxy Statement, if other than the Registrant)

    Payment of Filing Fee (Check all boxes that apply):

    ☒

    No fee required.

    ☐

    Fee paid previously with preliminary materials.

    ☐

    Fee computed on table in exhibit required by Item 25(b) per Exchange Act Rules 14a-6(i)(1) and 0-11.

    .


    GRAPHIC

    Step 1: Go to www.envisionreports.com/ACH. Step 2: Click on Cast Your Vote or Request Materials. Step 3: Follow the instructions on the screen to log in. www.envisionreports.com/ACH Online Go to www.envisionreports.com/ACH or scan the QR code — login details are located in the shaded bar below. Shareholder Meeting Notice 049L2C Important Notice Regarding the Availability of Proxy Materials for the Accendra Health, Inc. Shareholder Meeting to be Held on Thursday, May 14, 2026 Under Securities and Exchange Commission rules, you are receiving this notice that the proxy materials for the Annual Meeting of Shareholders are available on the Internet. Follow the instructions below to view the materials and vote online or request a copy. The items to be voted on and location of the annual meeting are on the reverse side. Your vote is important! This communication presents only an overview of the more complete proxy materials that are available to you on the Internet. We encourage you to access and review all of the important information contained in the proxy materials before voting. The Company’s 2026 Proxy Statement, the Proxy Card, the Company’s 2025 Annual Report/Form 10-K for the year ended December 31, 2025 (which is not deemed to be part of the official proxy soliciting materials), and any amendments to the foregoing materials that are required to be furnished to shareholders are available at: Obtaining a Copy of the Proxy Materials – If you want to receive a copy of the proxy materials, you must request one. There is no charge to you for requesting a copy. Please make your request as instructed on the reverse side on or before May 4, 2026 to facilitate timely delivery. 2NOT Easy Online Access — View your proxy materials and vote. When you go online, you can also help the environment by consenting to receive electronic delivery of future materials. Step 4: Make your selections as instructed on each screen for your delivery preferences. Step 5: Vote your shares. Votes submitted electronically must be received by May 13, 2026 at 11:59 p.m., Eastern Daylight Time

    GRAPHIC

    Here’s how to order a copy of the proxy materials and select delivery preferences: Current and future delivery requests can be submitted using the options below. If you request an email copy, you will receive an email with a link to the current meeting materials. PLEASE NOTE: You must use the number in the shaded bar on the reverse side when requesting a copy of the proxy materials. — Internet – Go to www.envisionreports.com/ACH. Click Cast Your Vote or Request Materials. — Phone – Call us free of charge at 1-866-641-4276. — Email – Send an email to [email protected] with “Proxy Materials Accendra Health, Inc.” in the subject line. Include your full name and address, plus the number located in the shaded bar on the reverse side, and state that you want a paper copy of the meeting materials. To facilitate timely delivery, all requests for a paper copy of proxy materials must be received by May 4, 2026. The 2026 Annual Meeting of Shareholders of Accendra Health, Inc. (the “Company”) will be held Thursday, May 14, 2026, at 9:00 a.m. Eastern Time, virtually via the internet at https://meetnow.global/M9CXXJJ. To access the virtual meeting, you must have the information that is printed in the shaded bar located on the reverse side of this form. Proposals to be voted on at the meeting are listed below. The Board of Directors recommends a vote FOR all the nominees listed and FOR Proposals 2, 3, and 4: 1. Election of six Directors, each for a one-year term and until their respective successors are elected and qualified: 01 - Mark A. Beck 02 - Gwendolyn M. Bingham 03 - Kenneth Gardner-Smith 04 - Stephen W. Klemash 05 - Teresa L. Kline 06 - Edward A. Pesicka 2. Ratification of the appointment of KPMG LLP as the Company’s independent registered public accounting firm for the year ending December 31, 2026. 3. Non-binding advisory vote to approve the compensation of the Company’s named executive officers. 4. Approval of the Accendra Health, Inc. Amended and Restated 2023 Omnibus Incentive Plan. 5. To transact any other business as may properly come before the Annual Meeting. The Board of Directors has fixed the close of business on March 18, 2026 as the record date (the “Record Date”) for the determination of shareholders entitled to receive notice of and to vote at the Annual Meeting or any adjournment(s) thereof. Shareholders of record as of the Record Date are encouraged and cordially invited to attend the virtual Annual Meeting. The following materials are available for you to review online: - the Company’s 2026 Proxy Statement (including all attachments thereto); - the Proxy Card; - the Company’s Annual Report/Form 10-K for the year ended December 31, 2025 (which is not deemed to be part of the official proxy soliciting materials); and - any amendments to the foregoing materials that are required to be furnished to shareholders. PLEASE NOTE – YOU CANNOT VOTE BY RETURNING THIS NOTICE. To vote your shares you must go online or request a paper copy of the proxy materials to receive a proxy card. Shareholder Meeting Notice

    Get the next $ACH alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACH

    DatePrice TargetRatingAnalyst
    8/25/2022Sell → Neutral
    Goldman
    3/23/2022Reduce → Hold
    HSBC Securities
    More analyst ratings

    $ACH
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Alum. Corp China upgraded by Goldman

    Goldman upgraded Alum. Corp China from Sell to Neutral

    8/25/22 1:04:06 PM ET
    $ACH
    Medical Specialities
    Health Care

    Alum. Corp China upgraded by HSBC Securities

    HSBC Securities upgraded Alum. Corp China from Reduce to Hold

    3/23/22 7:04:02 AM ET
    $ACH
    Medical Specialities
    Health Care

    Alum. Corp China upgraded by JP Morgan

    JP Morgan upgraded Alum. Corp China from Neutral to Overweight

    4/8/21 12:27:37 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 4 filed by Pesicka Edward A

    4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)

    3/24/26 5:45:07 PM ET
    $ACH
    Medical Specialities
    Health Care

    SEC Form 4 filed by Leon Jonathan A

    4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)

    3/24/26 5:42:40 PM ET
    $ACH
    Medical Specialities
    Health Care

    SEC Form 4 filed by Bernocchi Perry A

    4 - ACCENDRA HEALTH INC/VA/ (0000075252) (Issuer)

    3/24/26 5:40:48 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Accendra Health Reports Fourth Quarter 2025 Financial Results

    Completed Sale of Products & Healthcare Services Business On December 31, 2025 Strong Cash Flow and Debt Reduction In Quarter Accendra Health, Inc. (NYSE:ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. "We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are extremely excited to embark on the next chapter of our business as Accendra Health. The next several months w

    2/19/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

    Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A repl

    2/5/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health, Inc. to Begin Trading on NYSE under New Ticker "ACH"

    Accendra Health, Inc. (NYSE:ACH) (the "Company") announced that the Company's common stock will begin trading on the New York Stock Exchange under its new ticker symbol, "ACH", effective today. The Company also announced the launch of its new website, www.accendrahealth.com. On December 31, 2025, the Company announced the completion of the sale of its former Products & Healthcare Services business along with the Owens & Minor brand. Safe Harbor This release is intended to be disclosure through methods reasonably designed to provide broad, non-exclusionary distribution to the public in compliance with the SEC's Fair Disclosure Regulation. This release contains certain "forward looking" s

    1/2/26 6:30:00 AM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    SEC Filings

    View All

    SEC Form DEFA14A filed by Accendra Health Inc.

    DEFA14A - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    4/2/26 6:30:09 AM ET
    $ACH
    Medical Specialities
    Health Care

    SEC Form DEF 14A filed by Accendra Health Inc.

    DEF 14A - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    4/2/26 6:25:26 AM ET
    $ACH
    Medical Specialities
    Health Care

    SEC Form 10-K filed by Accendra Health Inc.

    10-K - ACCENDRA HEALTH INC/VA/ (0000075252) (Filer)

    2/20/26 4:19:33 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Financials

    Live finance-specific insights

    View All

    Accendra Health Reports Fourth Quarter 2025 Financial Results

    Completed Sale of Products & Healthcare Services Business On December 31, 2025 Strong Cash Flow and Debt Reduction In Quarter Accendra Health, Inc. (NYSE:ACH) today reported financial results for the fourth quarter ended December 31, 2025. Unless otherwise noted, the results herein reflect the Company's continuing operations, which primarily represent what was previously the Patient Direct segment and certain functional operations. "We ended the fourth quarter with the completion of the sale of the Products & Healthcare Services (P&HS) business on December 31, 2025, and we are extremely excited to embark on the next chapter of our business as Accendra Health. The next several months w

    2/19/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    Accendra Health Announces Fourth Quarter 2025 Earnings Release Date and Conference Call

    Accendra Health, Inc. (NYSE:ACH) (the "Company") plans to release financial results for the fourth quarter of 2025 on Thursday, February 19, 2026, after trading ends on the New York Stock Exchange. The Company will host a conference call for investors and analysts at 5:00 p.m. EST on the same day. Participants may access the call via the toll-free dial-in number at 1-888-300-2035, or the toll dial-in number at 1-646-517-7437. The conference ID access code is 1058917. All interested stakeholders are encouraged to access the simultaneous live webcast by visiting the Investor Relations page of the Accendra Health website available at investors.accendra.com/events-and-presentations/. A repl

    2/5/26 4:05:00 PM ET
    $ACH
    Medical Specialities
    Health Care

    $ACH
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    SEC Form SC 13G/A filed

    SC 13G/A - ALUMINUM CORP OF CHINA LTD (0001161611) (Subject)

    2/16/21 3:46:32 PM ET
    $ACH
    Medical Specialities
    Health Care